Back to News
Market Impact: 0.3
Eli Lilly Breaks Ground On $6.5 Bln Houston Manufacturing Facility
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsInfrastructure & Defense
Eli Lilly has begun construction of a $6.5 billion manufacturing facility in Houston, Texas. The plant will produce active pharmaceutical ingredients for Foundayo, other small-molecule medicines, and advanced therapeutics, expanding Lilly's pharmaceutical manufacturing capacity.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
LLY0.65
More News
- Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs
- Our top 10 things to watch in the stock market Friday
- Why is Hims & Hers Health stock rallying today?
- Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence
- Here's a rapid-fire update on all 31 of our stocks, including 2 to buy now
- How the US midterm elections reflected resistance to data centres